Lifeline Scientific

What Lifeline Scientific does

Lifeline Scientific, Inc. is a privately-held medical technology company founded in 1998 and headquartered in Itasca, Illinois. The company develops and markets advanced products and services for cell, tissue, and organ transplantation, with a mission centered on improving patient outcomes by helping deliver more and better-quality organs to transplant professionals worldwide. Its core product platform is LifePort, a normothermic machine perfusion system used for kidney preservation and transport, deployed across transplant programs in multiple countries. The company also offers a 24/7 Perfusion Helpline and LifePort Preservation Services for ongoing clinical support, and operates Organ Recovery Systems as a wholly-owned, globally distributed subsidiary serving as its market-facing commercialization channel.

The company's technology stack combines proprietary hardware (LifePort Kidney Transporter) with digital services: a Remote Monitoring & Tracking Web Portal for real-time organ transport status, a Mobile Troubleshooting App for field diagnostics, and an AI-assisted 24/7 helpline integrated with voice recording, transcription, and AI-powered messaging (A2P) for customer service. Co-development relationships with academic institutions and corporate partners align R&D priorities with major US and European clinical transplant society agendas in Basic, Translational, and Clinical Science. The company is currently certified under the EU-U.S., UK Extension, and Swiss-U.S. Data Privacy Frameworks (updated November 18, 2025), supporting cross-border data flows for its global customer base.

Lifeline generates revenue through two primary streams: (1) hardware sales of LifePort organ preservation machines, kidney transporters, and related devices to transplant programs and hospitals worldwide, and (2) managed preservation services delivered through its subsidiary Organ Recovery Systems. The company employs 501-1,000 people and distributes primarily via direct enterprise field sales targeting transplant programs, with marketing concentrated at academic and medical conferences. No specific pricing or revenue figures are publicly disclosed; distribution is global through Organ Recovery Systems.

Name

Lifeline Scientific

Legal name

Lifeline Scientific, Inc.

Website

https://lifeline-scientific.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Lifeline Scientific is a US-based medical technology company developing the LifePort normothermic machine perfusion platform and preservation services for organ, tissue, and cell transplantation, serving hospital transplant programs and procurement organizations worldwide through its subsidiary Organ Recovery Systems.

Ownership category

akta.pro rank

Product category

Organ Preservation Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

akta.pro secondary industries

Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), Life Sciences Cold Chain Logistics (2–8°C, -20°C, -80°C) (HLAGAMAA)

Keywords

• Organ preservation systems
• Machine perfusion technology
• Transplant medical devices
• Kidney preservation equipment
• Organ transport systems

Headquarters

HQ city

Itasca

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Organ Preservation Equipment Sales: Sale of LifePort organ preservation machines, kidney transporters, and related hardware to transplant programs and hospitals worldwide
2. Preservation Services: LifePort Preservation Services providing organ preservation support and related services

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Lifeline Scientific develops and markets advanced medical products and services for organ, tissue, and cell transplantation. Its core offering is the LifePort organ preservation and transport system, which uses normothermic machine perfusion technology to maintain organ viability during preservation and transport for transplant programs and hospitals worldwide. The company supplements its hardware with digital tools (remote monitoring portal and mobile troubleshooting app) and 24/7 support services distributed through its subsidiary Organ Recovery Systems.

Product overview

Lifeline Scientific, Inc. offers a unified product and service ecosystem centered on organ preservation and transplantation technology. The core product is LifePort, an organ preservation and transport system used globally for kidney transplantation. The company's branded market-facing subsidiary, Organ Recovery Systems, provides the product portfolio worldwide. The ecosystem includes supporting digital tools: the LifePort Mobile Troubleshooting App for field diagnostics, the LifePort Kidney Transporter Remote Monitoring & Tracking Web Portal for real-time organ transport monitoring, and 24/7 Perfusion Helpline and LifePort Preservation Services for round-the-clock support. The company develops AI-powered messaging and voice services to support these products and interacts with transplant professionals worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• LifePort: Organ preservation and transport system including LifePort Kidney Transporter, LifePort Preservation Services, and related mobile troubleshooting app
• Organ Recovery Systems

Products and services

• LifePort Organ Preservation System LifePort is Lifeline Scientific's primary organ preservation and transport system used by transplant programmes globally for preserving kidneys for transplantation. It is a key product in the organ recovery workflow based on normothermic machine perfusion technology.
• LifePort Kidney Transporter Specialized kidney preservation and transport device with remote monitoring and tracking capabilities, used by transplant programs and hospitals for organ transport logistics.
• Organ Recovery Systems (Subsidiary Service Brand) Wholly-owned subsidiary of Lifeline Scientific, Inc. and the company's branded market-facing organization providing innovative products and services worldwide for donor organ recovery, preservation, and transport to transplant programs and hospitals.
• LifePort Preservation Services Managed preservation services integrated with the LifePort product ecosystem, providing organ preservation support and related services to transplant programs, supported by 24/7 AI-enabled voice and messaging tools.

Quantifiable outcome

• Normothermic machine perfusion market projected to grow at 16.0% CAGR to $3.12 billion by 2030
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Academic InstitutionscoreStrategic or Co-development PartnerLifeline Scientific collaborates with academic institutions to develop innovations aimed at advancing the state of art of organ, tissue, and cell recovery and preservation to improve outcomes in transplantation. Development focus follows published priorities of major US and European clinical transplant societies in Basic Science, Translational Science, and Clinical Science areas.
• Corporate PartnerscoreStrategic or Co-development PartnerCorporate partnerships focused on developing proprietary technologies and innovations for organ recovery, preservation and transport. Collaborations aimed at advancing transplantation outcomes through joint development efforts.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Others

• CareDx: CareDx provides transplant diagnostics and digital solutions to transplant centers. It is an adjacent ecosystem participant serving the same hospital transplant programs that purchase Lifeline's preservation systems.
• Veloxis Pharmaceuticals: Veloxis specialises in immunosuppressants for transplant patients, addressing a downstream need in the transplantation ecosystem served by Lifeline's preservation technology.

Direct peers

• Preservation Solutions: Preservation Solutions manufactures organ preservation fluids and devices, competing in the same transplant supply chain as Lifeline Scientific.
• TransMedics: TransMedics develops the Organ Care System (OCS) for warm, beating organ preservation and transport, directly competing with Lifeline's LifePort normothermic perfusion technology across multiple organ types.
• Paragonix Technologies: Paragonix develops organ transport and preservation devices (e.g., SherpaPak, LIVERguard) for donor organ delivery, with a comparable hardware-plus-monitoring product strategy.
• Bridge to Life: Bridge to Life supplies organ preservation solutions and cold chain products for transplantation, overlapping with Lifeline's offerings to transplant centers and OPOs.
• OrganOx: OrganOx commercialises the metra normothermic liver perfusion device, competing with Lifeline in the machine perfusion space for organ transplantation.
• XVIVO Perfusion: Swedish-based XVIVO provides machine perfusion and preservation solutions for lungs, hearts, livers and kidneys, and is a direct peer in the organ transplantation technology market.
• Institut Georges Lopez (IGL): IGL is a major provider of organ preservation solutions including static cold storage fluids and devices used in transplant programs, directly competing with Lifeline Scientific in organ transport.

Regional players

• Organ Assist: Netherlands-based Organ Assist develops perfusion machines for kidneys, livers and other organs, making it a regionally focused peer with comparable machine perfusion technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lifeline-scientific

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lifeline Scientific